Mycophenolate Linked to Improvements with Scleroderma-related Interstitial Lung Disease

Researchers at the University of California David Geffen School of Medicine recently published data indicating that compared to a placebo, treatment with mycophenolate was linked to improvements in physiologic measures and dyspnea in scleroderma patients with interstitial lung disease.

A randomized trial looked at forced vital capacity%-predicted (FVC%) as the primary outcome. Secondary outcomes included diffusing capacity of the lung for carbon monoxide-predicted (DLCO%-predicted) and skin score, as well as dyspnea.

Read more >>

Patients are Driving Factor for Advances in Scleroderma Therapeutics

Some of the leading international pharmaceutical companies have products in clinical trial phases for treatment of scleroderma symptoms. Yet, a recent report from Transparency Market Research (TMR) indicates that key strategic collaborations will be key for advances in the scleroderma diagnostics and therapeutics market.

The scleroderma therapeutics market is driven by several different factors, such as a rise in clinical trials, a high acceptance of new therapies by patients, and new drug approvals for related conditions such as pulmonary arterial hypertension.

Read more >>

National Conference Keynote Speakers Announced

We are pleased to announce this year's keynote speakers for the 19th Annual National Patient Education Conference in Chandler, Ariz.

Returning this year to open the conference is Andrew Botieri, a motivational and thought leader expert. Andrew was diagnosed in 1999 with scleroderma and has authored the book, “A Celebration of Life - A Story of Hope, A Miracle and The Power of Attitude,” about his struggles and challenges of living with scleroderma using perseverance and a positive attitude.

This year's closing keynote will be presented by Karen Vasquez, who was diagnosed with scleroderma in 1994. Karen has been working as a scleroderma and chronic disease advocate for more than 20 years and will share how that tenacity saved her life more than once.

Read more and register for the conference

Don't miss news about this year's conference in Arizona. Sign-up for eAlerts today!

Important: Early Bird Registration Ends May 24 

Please note that early registration rates for this year's conference end on Wednesday, May 24. Register soon to take advantage of reduced rates.

Writing helps many people living with chronic illness cope and relieve stress. It can soothe your mind if life is feeling a bit chaotic or overwhelming. Some research studies have shown that it positively helps people work through issues.

You may want to consider setting some time aside each day to reflect about how scleroderma has affected your life through writing. Caring Voice Coalition offers a few writing prompts for people with chronic illness to help get you started.

Read more >>